Radiobiology Unit 5 ReviewDNA Damage and Repair Mechanisms

Introduction to DNA Damage

• DNA, the genetic blueprint of life, is constantly exposed to various endogenous and exogenous factors that can cause damage to its structure
• Endogenous sources of DNA damage include oxidative stress, hydrolysis, and replication errors
• Exogenous sources encompass ionizing radiation, UV light, and chemical agents (chemotherapeutic drugs, environmental toxins)
• DNA damage can manifest as single-strand breaks (SSBs), double-strand breaks (DSBs), base modifications, and crosslinks
• Accumulation of DNA damage can lead to genomic instability, mutations, and ultimately, the development of diseases such as cancer
• Cells have evolved intricate mechanisms to detect and repair DNA damage to maintain genomic integrity
• The efficiency of DNA repair processes declines with age, contributing to the aging process and age-related diseases

Types of DNA Damage

• Single-strand breaks (SSBs) occur when one strand of the DNA double helix is severed
  • SSBs are the most common type of DNA damage
  • Can be caused by reactive oxygen species (ROS), ionizing radiation, and certain chemicals
• Double-strand breaks (DSBs) involve the cleavage of both strands of the DNA double helix
  • DSBs are the most deleterious form of DNA damage
  • Can result from ionizing radiation, replication fork collapse, and certain chemotherapeutic agents (topoisomerase inhibitors)
• Base modifications involve chemical alterations to the nitrogenous bases (adenine, guanine, cytosine, thymine)
  • Examples include oxidation (8-oxoguanine), deamination (cytosine to uracil), and alkylation (methylation)
  • UV light can induce the formation of pyrimidine dimers (cyclobutane pyrimidine dimers, 6-4 photoproducts)
• Crosslinks are covalent bonds between two bases on the same strand (intrastrand) or opposite strands (interstrand)
  • Interstrand crosslinks (ICLs) are particularly cytotoxic as they prevent DNA strand separation during replication and transcription
  • Crosslinking agents include platinum-based chemotherapeutic drugs (cisplatin) and nitrogen mustards
• Abasic sites are locations in the DNA where a nitrogenous base is missing
  • Can arise from spontaneous hydrolysis or as intermediates during base excision repair (BER)
• Replication errors can introduce mismatched bases or small insertions/deletions (indels) in the DNA sequence
  • DNA polymerases have proofreading activity to minimize replication errors

Cellular Response to DNA Damage

• Cells have evolved a complex network of signaling pathways known as the DNA damage response (DDR) to detect and respond to DNA damage
• The DDR is initiated by sensor proteins that recognize DNA lesions and activate transducer proteins, which in turn activate effector proteins
• Key sensor proteins include ATM (ataxia telangiectasia mutated) and ATR (ATM and Rad3-related), which are activated by DSBs and replication stress, respectively
• Transducer proteins, such as Chk1 and Chk2, amplify the damage signal and activate downstream effector proteins
• Effector proteins, including p53, p21, and BRCA1, mediate various cellular responses to DNA damage
• The DDR can trigger cell cycle arrest to provide time for DNA repair before cell division
  • Checkpoints at G1/S, intra-S, and G2/M phases of the cell cycle prevent the propagation of damaged DNA to daughter cells
• In case of irreparable DNA damage, the DDR can induce apoptosis (programmed cell death) to eliminate the damaged cell
• Senescence, a state of permanent cell cycle arrest, can also be induced by persistent DNA damage
• The DDR activates DNA repair pathways specific to the type of DNA lesion detected

DNA Repair Mechanisms

• Cells employ several DNA repair mechanisms to restore the integrity of the genetic material
• Base excision repair (BER) corrects small base modifications, abasic sites, and SSBs
  • DNA glycosylases recognize and remove the damaged base, creating an abasic site
  • AP endonuclease cleaves the phosphodiester backbone at the abasic site
  • DNA polymerase fills the gap, and DNA ligase seals the nick
• Nucleotide excision repair (NER) removes bulky DNA adducts and UV-induced pyrimidine dimers
  • Global genome NER (GG-NER) surveys the entire genome for damage
  • Transcription-coupled NER (TC-NER) specifically repairs lesions on the transcribed strand of active genes
• Mismatch repair (MMR) corrects replication errors, such as mismatched bases and small insertions/deletions
  • MutSα (MSH2-MSH6) and MutSβ (MSH2-MSH3) recognize mismatches and initiate repair
  • MutLα (MLH1-PMS2) coordinates the excision of the mismatch-containing strand and resynthesis by DNA polymerase
• Double-strand break repair involves two main pathways: non-homologous end joining (NHEJ) and homologous recombination (HR)
  • NHEJ directly ligates the broken ends without the need for a homologous template
    • Ku70/80 heterodimer binds to the DSB ends and recruits DNA-PKcs
    • DNA ends are processed by nucleases and polymerases to make them compatible for ligation
    • DNA ligase IV-XRCC4 complex seals the break
  • HR uses the sister chromatid as a template for accurate repair
    • MRN complex (Mre11-Rad50-Nbs1) recognizes the DSB and initiates end resection
    • RPA binds to the single-stranded DNA overhangs and is replaced by Rad51 to form a nucleoprotein filament
    • Rad51 facilitates homology search and strand invasion into the sister chromatid
    • DNA polymerase extends the invading strand, and Holliday junctions are resolved to complete repair
• Interstrand crosslink repair involves the coordination of multiple repair pathways, including NER, HR, and translesion synthesis (TLS)
  • Fanconi anemia (FA) pathway plays a crucial role in the recognition and unhooking of ICLs
  • TLS polymerases (Pol η, Pol κ, Pol ι) can bypass DNA lesions during replication, albeit with reduced fidelity

Consequences of Unrepaired DNA Damage

• Accumulation of DNA damage can have severe consequences for cellular function and organismal health
• Mutations arising from unrepaired or incorrectly repaired DNA damage can alter gene function and contribute to cancer development
  • Oncogenes can be activated, and tumor suppressor genes can be inactivated by mutations
  • Mutations in DNA repair genes (BRCA1, BRCA2, MMR genes) predispose individuals to specific types of cancer (breast, ovarian, colorectal)
• Persistent DNA damage can lead to genomic instability, characterized by chromosomal aberrations and rearrangements
  • Chromosomal instability (CIN) is a hallmark of many cancers and is associated with poor prognosis
• Unrepaired DNA damage can trigger apoptosis, leading to cell death and tissue degeneration
  • Excessive apoptosis is implicated in neurodegenerative disorders (Alzheimer's, Parkinson's) and autoimmune diseases
• Senescence induced by DNA damage can contribute to tissue aging and age-related pathologies
  • Senescent cells secrete inflammatory factors (SASP) that can promote chronic inflammation and disrupt tissue homeostasis
• Defects in DNA repair pathways can cause various genetic disorders
  • Xeroderma pigmentosum (XP) results from defective NER and predisposes individuals to UV-induced skin cancers
  • Fanconi anemia (FA) is characterized by defective ICL repair and increased risk of leukemia and solid tumors
  • Ataxia telangiectasia (AT) is caused by mutations in ATM and leads to neurodegeneration, immunodeficiency, and cancer predisposition
• Unrepaired DNA damage in germ cells can lead to infertility and hereditary genetic disorders

Radiation-Induced DNA Damage

• Ionizing radiation (IR) is a potent inducer of DNA damage, particularly DSBs
• IR can cause direct DNA damage by ionizing DNA molecules or indirect damage through the generation of reactive oxygen species (ROS)
• The severity of radiation-induced DNA damage depends on the type and energy of the radiation, as well as the dose and dose rate
  • High-LET (linear energy transfer) radiation, such as alpha particles and heavy ions, causes more complex and clustered DNA damage compared to low-LET radiation (X-rays, gamma rays)
• Radiation-induced DSBs are often accompanied by base damage and SSBs in close proximity, forming complex DNA lesions
• The oxygen enhancement effect describes the increased biological effectiveness of IR in the presence of oxygen, as oxygen can stabilize DNA radicals and prevent their repair
• Radiosensitivity varies among different cell types and tissues
  • Rapidly dividing cells (bone marrow, intestinal epithelium) are more radiosensitive than slowly dividing or non-dividing cells (neurons)
• Individual genetic background can influence the response to radiation-induced DNA damage
  • Polymorphisms in DNA repair genes can modulate the efficiency of repair and the risk of radiation-induced toxicity
• Chronic exposure to low-dose radiation can lead to the accumulation of DNA damage and increased cancer risk
  • Radiation protection guidelines aim to minimize occupational and public exposure to ionizing radiation
• Radiation-induced bystander effect refers to the induction of DNA damage and biological effects in unirradiated cells through signals from nearby irradiated cells
  • Bystander effects can be mediated by gap junctions, soluble factors, and extracellular vesicles

Clinical Implications

• Understanding the mechanisms of DNA damage and repair has important clinical implications for the diagnosis, treatment, and prevention of diseases
• DNA repair deficiencies can be exploited for targeted cancer therapy
  • PARP inhibitors (olaparib, rucaparib) are effective in treating BRCA-deficient tumors by inducing synthetic lethality
  • Immune checkpoint inhibitors (anti-PD-1, anti-PD-L1) can be particularly effective in tumors with high levels of DNA damage and mutational burden (melanoma, lung cancer)
• Modulation of DNA repair pathways can enhance the efficacy of cancer treatments
  • Inhibition of DNA repair can sensitize cancer cells to chemotherapy and radiotherapy
  • Overexpression of DNA repair genes can confer resistance to DNA-damaging agents
• Biomarkers of DNA damage and repair can aid in the prediction of treatment response and prognosis
  • Levels of γH2AX, a marker of DSBs, can predict the response to radiotherapy and chemotherapy in various cancers
  • Mutations in DNA repair genes (BRCA1, BRCA2, MMR genes) can guide personalized cancer treatment and surveillance strategies
• Radiation therapy, a cornerstone of cancer treatment, relies on the induction of DNA damage in cancer cells
  • Fractionated radiotherapy exploits the differential DNA repair capacity of cancer cells and normal tissues
  • Hypofractionation (higher doses per fraction) can be more effective for tumors with defective DNA repair
  • Proton and carbon ion therapy can deliver high doses to the tumor while sparing surrounding normal tissues
• Preventive strategies aimed at minimizing DNA damage can reduce the risk of cancer and age-related diseases
  • Avoidance of excessive UV exposure, tobacco smoking, and other environmental carcinogens
  • Dietary interventions, such as antioxidant-rich foods and caloric restriction, can reduce oxidative DNA damage
  • Regular exercise and stress management can promote DNA repair and genomic stability
• Genetic counseling and testing for DNA repair gene mutations can inform cancer risk assessment and management
  • Individuals with germline mutations in BRCA1, BRCA2, or MMR genes may benefit from enhanced surveillance, prophylactic surgery, or chemoprevention
• Development of novel therapies targeting DNA repair pathways holds promise for improving cancer treatment outcomes
  • Synthetic lethality approaches aim to exploit DNA repair deficiencies in cancer cells while sparing normal cells
  • Combination therapies targeting multiple DNA repair pathways may overcome resistance and enhance therapeutic efficacy

Current Research and Future Directions

• Ongoing research aims to deepen our understanding of the complex mechanisms governing DNA damage and repair
• Advanced sequencing technologies, such as single-cell sequencing and long-read sequencing, are providing unprecedented insights into the genomic landscape of DNA damage and repair
  • Mapping of DNA damage sites at single-nucleotide resolution can reveal hotspots and patterns of damage
  • Characterization of DNA repair pathway choice and efficiency in different cell types and contexts
• High-throughput screening approaches are being employed to identify novel modulators of DNA repair pathways
  • Small molecule libraries, CRISPR-Cas9 screens, and RNA interference screens can uncover new therapeutic targets and biomarkers
• Computational modeling and systems biology approaches are integrating large-scale datasets to predict the consequences of DNA damage and repair perturbations
  • Mathematical models of DNA repair pathway dynamics and crosstalk can guide the design of optimal treatment strategies
  • Machine learning algorithms can predict the response to DNA-damaging agents based on genomic and epigenomic features
• Investigating the role of DNA damage and repair in aging and age-related diseases is an active area of research
  • Interventions targeting DNA repair pathways, such as senolytics and NAD+ precursors, are being explored for their potential to promote healthy aging
  • Understanding the interplay between DNA damage, cellular senescence, and inflammation may lead to new strategies for preventing and treating age-related pathologies
• Elucidating the impact of DNA damage and repair on the immune system and immunotherapy responses is a growing field of interest
  • DNA damage-induced inflammation and immunogenic cell death can modulate the tumor microenvironment and influence the efficacy of immunotherapies
  • Combining DNA repair inhibitors with immune checkpoint inhibitors may enhance anti-tumor immunity and overcome resistance
• Developing personalized approaches to cancer prevention and treatment based on individual DNA repair capacity and genetic background is a major goal
  • Tailoring screening and surveillance strategies based on DNA repair gene mutation status
  • Selecting optimal treatment regimens based on the DNA repair profile of the tumor and normal tissues
• Exploring the potential of DNA repair-based therapies for non-oncological diseases, such as neurodegenerative disorders and autoimmune diseases, is an emerging area of research
  • Modulating DNA repair pathways to prevent or reverse the accumulation of DNA damage in neurons
  • Targeting DNA repair defects in immune cells to treat autoimmune and inflammatory conditions
• Investigating the role of DNA damage and repair in embryonic development and stem cell biology may provide insights into congenital disorders and regenerative medicine
  • Understanding the DNA repair mechanisms that maintain genomic stability in embryonic and adult stem cells
  • Harnessing the potential of induced pluripotent stem cells (iPSCs) with enhanced DNA repair capacity for regenerative therapies
• Developing novel imaging techniques and biomarkers for non-invasive monitoring of DNA damage and repair in vivo is an important research direction
  • Radiolabeled probes and PET imaging of DNA repair enzymes and pathways
  • Liquid biopsy approaches for detecting circulating tumor DNA (ctDNA) and assessing DNA damage burden
• Collaborative efforts between basic scientists, clinicians, and industry partners are crucial for translating research findings into clinical practice and improving patient outcomes
  • Multidisciplinary teams combining expertise in DNA repair, cancer biology, radiation oncology, and medical oncology
  • Public-private partnerships to accelerate the development and clinical translation of DNA repair-based therapies